Sunday, September 27, 2026
BTC $84,373 ▼ 0.06%
Subscribe
Menu
NewsLive WirePoliticsWorldMarketsDigital AssetsTechnologySports
FranchisesThe BriefThe Big ReadThe BreakdownCrypto Culture
MoreDeFi & On-ChainU.S. EquitiesMacro & RatesResearch
LIVE
ADA$0.252down−0.86%ETH$2,695down−0.02%LINK$14.08down−0.47%SOL$120.45down−0.76%BTC$84,373down−0.06%XRP$1.51down−1.05%S&P 5007,743up+0.51%Nasdaq27,069up+0.48%Dow51,829up+0.93%RUT2,838up+0.07%TNX5.18%up+0.43%TYX5.50%up+0.79%FVX5.01%down−0.36%IRX4.07%up+0.05%VIX14.87down−5.11%GOLD$4,321.20up+0.54%SILVER$64.80up+1.25%OIL$92.41down−2.33%DXY101.03up+0.06%NVDA$225.07up+0.22%AAPL$341.07up+1.53%TSLA$372.11down−1.54%META$751.66down−3.33%MSFT$516.17up+3.66%AMZN$249.67up+0.12%GOOGL$343.92up+0.46%Fear & Greed70 — GreedADA$0.252down−0.86%ETH$2,695down−0.02%LINK$14.08down−0.47%SOL$120.45down−0.76%BTC$84,373down−0.06%XRP$1.51down−1.05%S&P 5007,743up+0.51%Nasdaq27,069up+0.48%Dow51,829up+0.93%RUT2,838up+0.07%TNX5.18%up+0.43%TYX5.50%up+0.79%FVX5.01%down−0.36%IRX4.07%up+0.05%VIX14.87down−5.11%GOLD$4,321.20up+0.54%SILVER$64.80up+1.25%OIL$92.41down−2.33%DXY101.03up+0.06%NVDA$225.07up+0.22%AAPL$341.07up+1.53%TSLA$372.11down−1.54%META$751.66down−3.33%MSFT$516.17up+3.66%AMZN$249.67up+0.12%GOOGL$343.92up+0.46%Fear & Greed70 — Greed
Tag

cancer screening

1 article

Jefferies Initiates Freenome With Buy, Sees 47% Upside in Cancer Screening
U.S. Equities40d ago
Jefferies Initiates Freenome With Buy, Sees 47% Upside in Cancer Screening
Jefferies set a $17 price target on Freenome (FRNM), trading at $11.56, citing the company's cancer screening potential as the core catalyst